# GYRE THERAPEUTICS INC (GYRE)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/GYRE/

- Reporting holders: 2
- Reported value: $3.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.6K | 361 | 0.0% | 2 |
| [GoalVest Advisory LLC](https://holderbook.com/funds/1839307-goalvest-advisory-llc/) | $367 | 50 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $3.0K |
| Q2 2026 | 63 | $60.0M |
| Q1 2026 | 55 | $23.8M |
| Q4 2025 | 43 | $23.7M |
| Q3 2025 | 46 | $23.1M |
| Q2 2025 | 47 | $25.1M |
| Q1 2025 | 44 | $20.1M |
| Q4 2024 | 39 | $22.7M |
| Q3 2024 | 36 | $21.3M |
| Q2 2024 | 31 | $16.1M |
| Q1 2024 | 20 | $16.3M |
| Q4 2023 | 16 | $18.3M |